SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Autophagy Enhancement Drug Screening for Neurodegeneration

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-experiments-autophagy-enhancement-d
Related Entities
experiments-autophagy-enhancement-drug-screening
Metadata
slugexperiments-autophagy-enhancement-drug-screening
entity_typeexperiment
kg_node_idNone
Linked Artifacts (1711)
derives_from🧫Autophagy Enhancement Drug Screening for Neurodegeneration95%
related🧪Temporal Decoupling via Circadian Clock Reset80%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination80%
related🧪Netrin-1 Gradient Restoration80%
related🧪Smartphone-Detected Motor Variability Correction80%
related🧪Purinergic Signaling Polarization Control80%
related🧪Mitochondrial-Lysosomal Contact Site Engineering80%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 80%
related🧪Circadian-Synchronized Proteostasis Enhancement80%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration80%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement80%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer80%
related🧪Ganglioside Rebalancing Therapy80%
related🧪Mitochondrial SPM Synthesis Platform Engineering80%
related🧪CX43 hemichannel engineering enables size-selective mitochon80%
related🧪Arginine Methylation Enhancement Therapy80%
related🧪Senescent Cell Mitochondrial DNA Release80%
related🧪SASP-Mediated Cholinergic Synapse Disruption80%
related🧪Mitochondrial RNA Granule Rescue Pathway80%
related🧪Multi-Modal Stress Response Harmonization80%
related🧪Complement C1q Mimetic Decoy Therapy80%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu80%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc80%
related🧪CYP46A1 Overexpression Gene Therapy80%
related🧪Enteric Nervous System Prion-Like Propagation Blockade80%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m80%
related🧪Retinal Vascular Microcirculation Rescue80%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition80%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho80%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation80%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi80%
related🧪Noradrenergic-Tau Propagation Blockade80%
related🧪Adenosine-Astrocyte Metabolic Reset80%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho80%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones80%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors80%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists80%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations80%
related🧪Quantum Coherence Disruption in Cellular Communication80%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation80%
related🧪Cryptic Exon Silencing Restoration80%
related🧪SIRT6-NAD+ Axis Enhancement Therapy80%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics80%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes80%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem80%
related🧪SASP-Mediated Complement Cascade Amplification80%
related🧪Complement C1q Subtype Switching80%
related🧪Microglial Purinergic Reprogramming80%
related🧪Heat Shock Protein 70 Disaggregase Amplification80%
related🧪Autophagosome Maturation Checkpoint Control80%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener80%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal80%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement80%
related🧪Sphingolipid Metabolism Reprogramming80%
related🧪PARP1 Inhibition Therapy80%
related🧪Low Complexity Domain Cross-Linking Inhibition80%
related🧪Ocular Immune Privilege Extension80%
related🧪Hypocretin-Neurogenesis Coupling Therapy80%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation80%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu80%
related🧪Extracellular Matrix Stiffness Modulation80%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism80%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation80%
related🧪Perforant Path Presynaptic Terminal Protection Strategy80%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor80%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset80%
related🧪Senescence-Induced Lipid Peroxidation Spreading80%
related🧪Piezoelectric Nanochannel BBB Disruption80%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis80%
related🧪Lipid Droplet Dynamics as Phenotype Switches80%
related🧪Circadian-Synchronized LRP1 Pathway Activation80%
related🧪Glycine-Rich Domain Competitive Inhibition80%
related🧪SASP-Driven Aquaporin-4 Dysregulation80%
related🧪Axonal RNA Transport Reconstitution80%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In80%
related🧪Circadian-Gated Maresin Biosynthesis Amplification80%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming80%
related🧪Orexin-Microglia Modulation Therapy80%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation80%
related🧪Lysosomal Membrane Repair Enhancement80%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement80%
related🧪Lysosomal Calcium Channel Modulation Therapy80%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue80%
related🧪Blood-Brain Barrier SPM Shuttle System80%
related🧪Mitochondrial Transfer Pathway Enhancement80%
related🧪Stress Granule Phase Separation Modulators80%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr80%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction80%
related🧪Pharmacological Enhancement of APOE4 Glycosylation80%
related🧪Membrane Cholesterol Gradient Modulators80%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto80%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu80%
related🧪Flotillin-1 Stabilization Compounds80%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization80%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy80%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling80%
related🧪HDAC3-Selective Inhibition for Clock Reset80%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering80%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati80%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th80%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation80%
related🧪Transcriptional Autophagy-Lysosome Coupling80%
related🧪Digital Twin-Guided Metabolic Reprogramming80%
related🧪Lysosomal Positioning Dynamics Modulation80%
related🧪Lysosomal Enzyme Trafficking Correction80%
related🧪Circadian Clock-Autophagy Synchronization80%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides80%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri80%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai80%
related🧪Senescence-Associated Myelin Lipid Remodeling80%
related🧪Glial Glycocalyx Remodeling Therapy80%
related🧪R-Loop Resolution Enhancement Therapy80%
related🧪Aquaporin-4 Polarization Rescue80%
related🧪Senescence-Activated NAD+ Depletion Rescue80%
related🧪Competitive APOE4 Domain Stabilization Peptides80%
related🧪Epigenetic Memory Erasure via TET2 Activation80%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol80%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy80%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy80%
related🧪Mechanosensitive Ion Channel Reprogramming80%
related🧪Serine/Arginine-Rich Protein Kinase Modulation80%
related🧪Selective Acid Sphingomyelinase Modulation Therapy80%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)80%
related🧪Vocal Cord Neuroplasticity Stimulation80%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme80%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors80%
related🧪Ephrin-B2/EphB4 Axis Manipulation80%
related🧪Microbial Inflammasome Priming Prevention80%
related🧪Phase-Separated Organelle Targeting80%
related🧪Nucleolar Stress Response Normalization80%
related🧪Vagal Afferent Microbial Signal Modulation80%
related🧪Cross-Seeding Prevention Strategy80%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution80%
related🧪Purinergic P2Y12 Inverse Agonist Therapy80%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection80%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat80%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch80%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming80%
related🧪Sphingomyelin Synthase Activators for Raft Remodeling80%
related🧪RNA Granule Nucleation Site Modulation80%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration80%
see_also📖Exosomal Biomarkers in Neurodegeneration80%
see_also📖Exosomal miR-155 in Neurodegeneration80%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration80%
see_also📖Liquid Biopsy in Neurodegeneration80%
see_also📖Metabolomic Biomarkers in Neurodegeneration80%
see_also📖Neuroimaging Biomarkers for Neurodegeneration80%
see_also📖Synaptic Biomarkers in Neurodegeneration80%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and80%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl80%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 80%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)80%
see_also📖China Neurodegeneration Epidemiology80%
see_also📖DALY Methodology — Neurodegeneration80%
see_also📖Disease Progression & Staging in Neurodegeneration80%
see_also📖Economic Burden — Neurodegeneration80%
see_also📖European Neurodegeneration Epidemiology80%
see_also📖Familial vs Sporadic Neurodegeneration Comparison80%
see_also📖Global Neurodegeneration Epidemiology80%
see_also📖India Neurodegeneration Epidemiology80%
see_also📖Japan Neurodegeneration Epidemiology80%
see_also📖Manganese-Related Neurodegeneration (Manganism)80%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison80%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr80%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 80%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)80%
see_also📖Potential Impact Measures — Neurodegeneration80%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)80%
see_also📖Sleep Disorders in Neurodegeneration80%
see_also📖US Neurodegeneration Epidemiology80%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread80%
see_also📖acetylcholine-signaling-neurodegeneration80%
see_also📖Advanced Glycation End Products in Neurodegeneration80%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 80%
see_also📖Amylin Signaling in Neurodegeneration80%
see_also📖Antibody Therapy in Neurodegeneration80%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration80%
see_also📖Autosis Pathway in Neurodegeneration80%
see_also📖Axon Guidance Pathways in Neurodegeneration80%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration80%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain80%
see_also📖CaMKII Signaling Pathway in Neurodegeneration80%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration80%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration80%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration80%
see_also📖Cholinergic System Dysfunction in Neurodegeneration80%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat80%
see_also📖Neural Circuits in Neurodegeneration80%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration80%
see_also📖Computational Disease Models for Neurodegeneration80%
see_also📖Convergent Pathways in Neurodegeneration80%
see_also📖Copper Homeostasis in Neurodegeneration80%
see_also📖COVID-19 Neurodegeneration Mechanism80%
see_also📖Diffusion MRI (DTI) in Neurodegeneration80%
see_also📖Digital Phenotyping in Neurodegeneration80%
see_also📖Down Syndrome Neurodegeneration Pathway80%
see_also📖Dystrophic Neurites in Neurodegeneration80%
see_also📖Endocannabinoid System in Neurodegeneration80%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration80%
see_also📖Endosomal Sorting Defects in Neurodegeneration80%
see_also📖Endothelin Signaling Pathway in Neurodegeneration80%
see_also📖epigenetics-neurodegeneration80%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration80%
see_also📖FA2H-Associated Neurodegeneration Pathway80%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration80%
see_also📖Galectin-3 Mechanism in Neurodegeneration80%
see_also📖Gangliosides in Neurodegeneration80%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration80%
see_also📖GDNF Signaling Pathway in Neurodegeneration80%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration80%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration80%
see_also📖Glycosylation in Neurodegeneration80%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration80%
see_also📖Hippocampal Neurogenesis in Neurodegeneration80%
see_also📖Histone Modification Pathways in Neurodegeneration80%
see_also📖HMGB1 Signaling in Neurodegeneration80%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration80%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration80%
see_also📖IL-1 Signaling Pathway in Neurodegeneration80%
see_also📖Integrated Stress Response in Neurodegeneration80%
see_also📖interleukin-6-signaling-neurodegeneration80%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration80%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 80%
see_also📖Kidney-Brain Neurodegeneration Axis80%
see_also📖Lipid Dysregulation in Neurodegeneration80%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration80%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration80%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration80%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration80%
see_also📖Metal Homeostasis in Neurodegeneration80%
see_also📖Microglial Priming Pathway in Neurodegeneration80%
see_also📖MicroRNA Dysfunction in Neurodegeneration80%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration80%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration80%
see_also📖Mitochondrial Fusion in Neurodegeneration80%
see_also📖Molecular Chaperones in Neurodegeneration80%
see_also📖mTOR Signaling in Neurodegeneration80%
see_also📖mTOR Signaling Pathway in Neurodegeneration80%
see_also📖Neural Circuit Disruption in Neurodegeneration80%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N80%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati80%
see_also📖Neuronal Hyperexcitability in Neurodegeneration80%
see_also📖Neuropil Threads in Neurodegeneration80%
see_also📖Neurotensin Signaling in Neurodegeneration80%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration80%
see_also📖NF-kB Signaling Pathway in Neurodegeneration80%
see_also📖Nitric Oxide Signaling in Neurodegeneration80%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration80%
see_also📖Neuropeptide Y Signaling in Neurodegeneration80%
see_also📖NRF2 Signaling Pathway in Neurodegeneration80%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration80%
see_also📖Orexin Signaling in Neurodegeneration80%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration80%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration80%
see_also📖Paranodal Dysfunction in Neurodegeneration80%
see_also📖Paraptosis in Neurodegeneration80%
see_also📖Parthanatos in Neurodegeneration80%
see_also📖Pericyte Loss in Neurodegeneration80%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration80%
see_also📖PKR Pathway in Neurodegeneration80%
see_also📖PPAR Signaling Pathway in Neurodegeneration80%
see_also📖Prion Diseases in Neurodegeneration80%
see_also📖Prion-Like Spread in Neurodegeneration80%
see_also📖Prion Protein Metabolism in Neurodegeneration80%
see_also📖Progesterone Signaling Pathway in Neurodegeneration80%
see_also📖Prognostic Biomarkers in Neurodegeneration80%
see_also📖Protein Aggregation Comparison in Neurodegeneration80%
see_also📖Protein Aggregation Seeds in Neurodegeneration80%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration80%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su80%
see_also📖Purinergic Signaling in Neurodegeneration80%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener80%
see_also📖R-Loop Stress in Neurodegeneration80%
see_also📖RAN Translation in Neurodegeneration80%
see_also📖Retinal Degeneration Pathway in Neurodegeneration80%
see_also📖Ribosome Dysfunction in Neurodegeneration80%
see_also📖RNA Splicing in Neurodegeneration80%
see_also📖RNA-Targeted Therapies in Neurodegeneration80%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a80%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration80%
see_also📖Senescent Cell Clearance in Neurodegeneration80%
see_also📖Serotonergic Dysfunction in Neurodegeneration80%
see_also📖Sex Differences in Neurodegeneration80%
see_also📖Short Chain Fatty Acids in Neurodegeneration80%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration80%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration80%
see_also📖Sleep Dysfunction in Neurodegeneration80%
see_also📖SUMOylation in Neurodegeneration80%
see_also📖synaptic-vesicle-cycling-neurodegeneration80%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration80%
see_also📖T-Cell Dysfunction in Neurodegeneration80%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration80%
see_also📖Therapeutic Targets in Neurodegeneration80%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration80%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration80%
see_also📖Vagus Nerve Pathway in Neurodegeneration80%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio80%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio80%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen80%
see_also📖WNK1 Kinase in Neurodegeneration80%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration80%
see_also📖Neuroimaging for Parkinsonian Syndromes (NCT03872102)80%
see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%
see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE75%
see_also📖UPenn Observational Research Repository (NCT04715399)75%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
see_also📖APOE4 (Apolipoprotein E4)70%
see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 65%
see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial65%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St65%
see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739265%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime65%
see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD60%
see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)60%
see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M60%
see_also📖nct0550878960%
see_also📖PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD60%
see_also📖remternetug-anti-amyloid-alzheimers60%
see_also📖APOE2 (Apolipoprotein E2)60%
see_also📖APOE3 (Apolipoprotein E3)60%
see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas60%
see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc60%
see_also📖SNCA Gene Variants and Mutations60%
see_also📖SNCA — Alpha-Synuclein Gene Entity Page60%
see_also📖PSP Liquid-Liquid Phase Separation and Biomolecular Condensa60%
mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration60%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur60%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi60%
related🧫Proposed experiment from debate on Epigenetic clocks and bio60%
related🧫Proposed experiment from debate on Microglia activate astroc60%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur60%
related🧫Proposed experiment from debate on Epigenetic clocks and bio60%
related🧫s:** - Temporal analysis showing mitochondrial defects prece60%
related🧫s:** - Test MCU overexpression specifically in layer II neur60%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l60%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l60%
related🧫s:** - Compare uptake with/without magnetic particles using 60%
related🧫Proposed experiment from debate on Perivascular spaces and g60%
related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice60%
related🧫Proposed experiment from debate on Mitochondrial transfer be60%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional60%
related🧫Proposed experiment from debate on Perivascular spaces and g60%
related🧫Proposed experiment from debate on Mitochondrial transfer be60%
related🧫s:** - Dose-response studies showing therapeutic window with60%
related🧫Proposed experiment from debate on Senolytics targeting p16/60%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy60%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka60%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi60%
related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr60%
related🧫DLB Cognitive Fluctuation Mechanism Experiment60%
related🧫Genetic Risk Modifiers in DLB Phenotype60%
related🧫Tau Co-Pathology in DLB Clinical Heterogeneity60%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras60%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther60%
related🧫Experiment Index60%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M60%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin60%
related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment60%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design60%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre60%
related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 60%
related🧫NPH Glymphatic System Interaction Experiment60%
related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G60%
related🧫Prion Strain Diversity and Selective Vulnerability in CJD60%
related🧫Protein Aggregation Kinetic Validation Results60%
related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel60%
related🧫Experiment Scoring Methodology60%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec60%
related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati60%
related🧫Tau Pathology Initiation Zone Identification60%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo60%
related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro60%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in60%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an60%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 60%
see_also📖Ubiquitin C-terminal Hydrolase L1 (UCH-L1)60%
see_also📖Cocaine- and Amphetamine-Regulated Transcript (CART) Neurons60%
see_also📖Hypoxia-Sensitive Dopaminergic Neurons60%
see_also📖Hypoxia-Sensitive Neurons60%
see_also📖metformin-add-on-levodopa-pd-nct0705595860%
see_also📖Metformin for Parkinson's Disease - Phase 2/3 Trial (NC60%
see_also📖entities-gba160%
see_also📖UBQLN2 Protein (Ubiquilin-2)60%
see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%
see_also📖ADAM8 Gene60%
see_also📖AKT2 Gene60%
see_also📖ap2a160%
see_also📖AP2M1 Gene60%
see_also📖APEX2 Gene60%
see_also📖ARAF Gene60%
see_also📖ARSA Gene60%
see_also📖ATG160%
see_also📖ATG10 Gene60%
see_also📖ATG2B60%
see_also📖ATG4A Gene60%
see_also📖ATP1B1 Gene60%
see_also📖atp6v0d160%
see_also📖BIP — Binding Immunoglobulin Protein60%
see_also📖BLM — Bloom Syndrome Protein60%
see_also📖BRCA1 Gene60%
see_also📖BRCA2 Gene60%
see_also📖BTRC Gene60%
see_also📖CASP2 Gene60%
see_also📖CCL3 Gene60%
see_also📖CCL4 Gene60%
see_also📖ccl560%
see_also📖CCR5 Gene60%
see_also📖CDK12 — Cyclin-Dependent Kinase 1260%
see_also📖CDK4 Gene60%
see_also📖CEBPB Gene60%
see_also📖CERS2 — Ceramide Synthase 2 (Lass2)60%
see_also📖CFH60%
see_also📖CHMP4B — Charged Multivesicular Body Protein 4B60%
see_also📖CHUK — IKK Alpha (IκB Kinase Alpha)60%
see_also📖CKAP4 — Cytoskeleton-Associated Protein 460%
see_also📖CLN5 Gene - Ceroid Lipofuscinosis, Neuronal 560%
see_also📖CNTNAP3 Gene - Contactin Associated Protein 360%
see_also📖COX4I160%
see_also📖CRHR160%
see_also📖csf160%
see_also📖CTSZ Gene - Cathepsin Z60%
see_also📖CUL3 — Cullin 360%
see_also📖CXCR3 Gene60%
see_also📖ddb160%
see_also📖DDX6 Gene60%
see_also📖DES Gene60%
see_also📖DIABLO60%
see_also📖DNMT1 Gene60%
see_also📖E2F4 Gene60%
see_also📖ECSIT — Evolutionarily Conserved Signaling Intermediate in T60%
see_also📖EGR1 Gene60%
see_also📖ELAVL1 Gene60%
see_also📖ELAVL3 Gene60%
see_also📖ELAVL4 Gene60%
see_also📖ELMO1 - Engulfment and Cell Motility 160%
see_also📖ELP3 Gene60%
see_also📖ENDOG60%
see_also📖ERK2 (MAPK1)60%
see_also📖ERP57 (PDIA3) — Protein Disulfide Isomerase Family A Member 60%
see_also📖FER Gene60%
see_also📖FGFR1 — Fibroblast Growth Factor Receptor 160%
see_also📖FIS1 Gene60%
see_also📖FLCN Gene60%
see_also📖foxo460%
see_also📖GABARAPL2 Gene60%
see_also📖GAL Gene60%
see_also📖GBA1 — Glucocerebrosidase60%
see_also📖GDAP1 — Ganglioside-Induced Differentiation-Associated Prote60%
see_also📖GLI1 — GLI Family Zinc Finger 160%
see_also📖GRIA2 Gene60%
see_also📖herc560%
see_also📖HNRNPH1 Gene60%
see_also📖HSPA5 — Heat Shock Protein Family A (Hsp70) Member 560%
see_also📖HSPD1 Gene - Heat Shock Protein Family D Member 160%
see_also📖HTRA2 Gene60%
see_also📖IFNG Gene60%
see_also📖IKBKB Gene60%
see_also📖IL23A Gene60%
see_also📖IRF1 Gene - Interferon Regulatory Factor 160%
see_also📖IRF3 Gene60%
see_also📖ISG15 — Interferon-Stimulated Gene 1560%
see_also📖JAK1 — Janus Kinase 160%
see_also📖KAT8 Gene60%
see_also📖KDM6B (JMJD3)60%
see_also📖KLF4 Gene60%
see_also📖LAMTOR1 - Late Endosomal/Lysosomal Adaptor 160%
see_also📖LAPTM4B Gene60%
see_also📖LATS1 — Large Tumor Suppressor Kinase 1, Hippo Pathway60%
see_also📖LCK — LCK Proto-Oncogene, Src Family Tyrosine Kinase60%
see_also📖LGMN Gene60%
see_also📖LRPPRC — Leucine-Rich Pentatricopeptide Repeat Containing60%
see_also📖MAP1B Gene60%
see_also📖MAP2 Gene60%
see_also📖MAP3K7 Gene60%
see_also📖MARK2 Gene60%
see_also📖MCL1 Gene - Myeloid Cell Leukemia 160%
see_also📖MERTK - MER Tyrosine Kinase60%
see_also📖MITF Gene — Microphthalmia-Associated Transcription Factor60%
see_also📖MYO7A — Myosin VIIa60%
see_also📖MYOT Gene60%
see_also📖nfatc260%
see_also📖NOS2 - Nitric Oxide Synthase 260%
see_also📖NPAS4 Gene60%
see_also📖NR1H3 - Nuclear Receptor Subfamily 1 Group H Member 360%
see_also📖NR4A1 Gene60%
see_also📖NTS — Neurotensin60%
see_also📖NURR1 Gene60%
see_also📖OGG1 Gene60%
see_also📖OSMR Gene60%
see_also📖PARK2 - Parkin60%
see_also📖PCBP1 Gene60%
see_also📖PGK1 Gene60%
see_also📖PHF8 (PHD Finger Protein 8)60%
see_also📖PLCG1 - Phospholipase C Gamma 160%
see_also📖PLD3 Gene60%
see_also📖PPM1B Gene60%
see_also📖PRDX1 Gene60%
see_also📖prdx660%
see_also📖PRKAA2 (AMPKα2) — AMP-Activated Protein Kinase Catalytic Sub60%
see_also📖PSMB860%
see_also📖PTBP1 Gene60%
see_also📖rab10 Gene60%
see_also📖RANBP2 — RAN Binding Protein 260%
see_also📖RAPTOR Gene60%
see_also📖RNF260%
see_also📖ROCK1 Gene60%
see_also📖SFN Gene60%
see_also📖SIRT5 - Sirtuin 560%
see_also📖slc1a560%
see_also📖SMAC Gene60%
see_also📖SMAD2 Gene60%
see_also📖SMAD3 — SMAD Family Member 360%
see_also📖SMARCA460%
see_also📖SOCS3 - Suppressor of Cytokine Signaling 360%
see_also📖SPHK1 — Sphingosine Kinase 160%
see_also📖SPTLC1 - Serine Palmitoyltransferase60%
see_also📖STAT2 Gene - Signal Transducer and Activator of Transcriptio60%
see_also📖STX11 Gene60%
see_also📖SYT1 — Synaptotagmin 160%
see_also📖TAK1 Gene60%
see_also📖TGFBR2 (Transforming Growth Factor Beta Receptor 2)60%
see_also📖TMEM173 (STING)60%
see_also📖tmx260%
see_also📖TNF Gene60%
see_also📖TNFRSF1A Gene60%
see_also📖TOMM7060%
see_also📖TPX260%
see_also📖TRAF6 Gene60%
see_also📖TREH — Trehalase60%
see_also📖TREM1 — Triggering Receptor Expressed on Myeloid Cells 160%
see_also📖TRIM32 Gene60%
see_also📖TSC2 — Tuberous Sclerosis Complex 260%
see_also📖TUBB3 Gene60%
see_also📖ubqln160%
see_also📖ubqln260%
see_also📖UCHL1 Gene60%
see_also📖UFM1 — Ubiquitin-like Modifier 160%
see_also📖USP30 — Ubiquitin Specific Peptidase 3060%
see_also📖VCP — Valosin-Containing Protein60%
see_also📖VDAC1 — Voltage Dependent Anion Channel 160%
see_also📖VDAC2 — Voltage-Dependent Anion Channel 260%
see_also📖vdr60%
see_also📖VMAT2 Gene60%
see_also📖VPS11 — Vacuolar Protein Sorting 1160%
see_also📖WIF1 Gene - Wnt Inhibitory Factor60%
see_also📖WIPI1 Gene60%
see_also📖xbp160%
see_also📖YAP1 — Yes-Associated Protein 160%
see_also📖zdhhc1360%
see_also📖GBA1 Gaucher Disease Modulator for Parkinson's Disease60%
see_also📖SARM1 NADase Inhibition Therapy60%
see_also📖TREM1-TREM2 Balanced Microglial Modulation Therapy60%
see_also📖SARM1 NADase Inhibition for Axonal Preservation60%
see_also📖ACLY Inhibition Rescues Alpha-Synuclein Autophagy60%
see_also📖Arsenic Exposure and Alzheimer's Disease Mechanism60%
see_also📖Axonal Transport60%
see_also📖Chaperone-Mediated Autophagy in Neurodegeneration60%
see_also📖Chaperone-Mediated Autophagy in Neurodegeneration60%
see_also📖Extracellular Matrix in Neurodegeneration60%
see_also📖Extracellular Matrix and Perineuronal Nets in 4R-Tauopathies60%
see_also📖FOXO Signaling Pathway in Neurodegeneration60%
see_also📖Hypoxia Neuroprotection in Sporadic Parkinson's Disease60%
see_also📖Hypoxia Response Pathway60%
see_also📖Lysosomal Dysfunction in Neurodegeneration60%
see_also📖Lysosomal Dysfunction in Progressive Supranuclear Palsy60%
see_also📖MAPK/ERK Signaling Pathway in Neurodegeneration60%
see_also📖MAPK/ERK Signaling Pathway in Neurodegeneration60%
see_also📖MAPK/ERK and JAK-STAT Signaling in 4R-Tauopathies60%
see_also📖Melatonin Signaling Pathway in Neurodegeneration60%
see_also📖Remyelination in Neurodegeneration60%
see_also📖sarm1-programmed-axon-degeneration60%
see_also📖A-Raf Protein60%
see_also📖ATP1B1 Protein60%
see_also📖BiP - Binding Immunoglobulin Protein (GRP78)60%
see_also📖Caspase 2 (CASP2)60%
see_also📖Cathepsin S Protein60%
see_also📖CCL5 Protein60%
see_also📖CCR5 Protein60%
see_also📖Dynactin Protein60%
see_also📖ERK2 Protein60%
see_also📖Fission 1 (FIS1)60%
see_also📖GBA1 Protein (Glucocerebrosidase)60%
see_also📖HSP60 (Heat Shock Protein 60)60%
see_also📖LRPPRC Protein60%
see_also📖MAP1B Protein60%
see_also📖MAP2 Protein — Microtubule-Associated Protein 260%
see_also📖Nuclear Receptor Related 1 (NURR1)60%
see_also📖proteins-pgc-1a-protein60%
see_also📖Phospholipase C Gamma 1 Protein60%
see_also📖PRDX1 Protein (Peroxiredoxin 1)60%
see_also📖TAK1 Protein60%
see_also📖TOMM70 Protein60%
see_also📖TRAF6 Protein60%
see_also📖TRAF6 Protein60%
see_also📖TRIM32 Protein60%
see_also📖TUBB3 Protein60%
see_also📖UBQLN2 Protein60%
see_also📖UBQLN2 Protein60%
see_also📖VCP (Valosin-Containing Protein)60%
see_also📖WIPI1 Protein60%
see_also📖XBP1 - X-Box Binding Protein 160%
see_also📖Extracellular Matrix and Integrin Modulator Therapy for Neur60%
see_also📖Longevity and Rejuvenation Therapies Landscape60%
see_also📖Melatonin Agonist Therapy for Neurodegeneration60%
see_also📖Melatonin for Tauopathy: Comprehensive Evidence Synthesis60%
see_also📖Melatonin Therapy for Neurodegenerative Diseases60%
see_also📖melatonin-therapy-parkinsons60%
see_also📖Metformin for Neurodegeneration60%
see_also📖nadph-oxidase-inhibitors60%
see_also📖Neuroprotection Strategies in Neurodegeneration60%
see_also📖Resveratrol and Sirtuin Activation for Neurodegeneration60%
see_also📖SARM1 Inhibitor Therapy60%
see_also📖sarm1-inhibitors-neurodegeneration60%
see_also📖spermidine-neurodegeneration60%
see_also📖Trehalose for Neurodegenerative Diseases60%
see_also📖TDP-43 (TAR DNA-Binding Protein 43) - Biomarker60%
see_also📖ABCA7 (Redirect)60%
see_also📖ARNTL Gene — Aryl Hydrocarbon Receptor Nuclear Translocator 60%
see_also📖ATG16L2 Gene60%
see_also📖ATG17 Gene60%
see_also📖AXIN2 Gene60%
see_also📖BRD4 (Bromodomain-Containing Protein 4)60%
see_also📖C19orf12 Gene - Chromosome 19 Open Reading Frame 1260%
see_also📖CASP4 Gene60%
see_also📖casp960%
see_also📖CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A60%
see_also📖CHMP7 mutations cause hereditary spastic paraplegia60%
see_also📖CLPP (Caseinolytic Mitochondrial Matrix Peptidase Proteolyti60%
see_also📖COASY Gene60%
see_also📖CTCF Gene60%
see_also📖DCAF17 Gene - DDB1 and CUL4 Associated Factor 1760%
see_also📖DNAJB1 Gene60%
see_also📖DNAJB6 Gene60%
see_also📖DNAJC6 — DnaJ Heat Shock Protein Family Member A660%
see_also📖DRAM1 Gene60%
see_also📖DRD1 Gene60%
see_also📖ELAVL2 Gene60%
see_also📖EPG5 Gene - Ectopic P-Granules 5 Autophagy Tutor60%
see_also📖ERLIN1 Gene60%
see_also📖ESRRG Gene60%
see_also📖fa2h60%
see_also📖FANCD2 Gene60%
see_also📖FLNC Gene60%
see_also📖FTH1 Gene — Ferritin Heavy Chain 160%
see_also📖FYCO1 — FYVE and Coiled-Coil Domain Containing 160%
see_also📖GABARAPL1 — GABA Type A Receptor Associated Protein Like 160%
see_also📖GAK Gene60%
see_also📖GCLM — Glutamate-Cysteine Ligase Modifier Subunit60%
see_also📖GNAI3 — G Protein Subunit Alpha I360%
see_also📖GNB4 Gene — G Protein Subunit Beta 460%
see_also📖got160%
see_also📖GPT - Alanine Transaminase (ALT)60%
see_also📖H2AX Gene60%
see_also📖hsp90ab160%
see_also📖hspb860%
see_also📖IKBKE (IKKε)60%
see_also📖ITPR1 - Inositol 1,4,5-Trisphosphate Receptor Type 160%
see_also📖JUNB Gene60%
see_also📖KANSL1 — KAT8 Regulatory NSL Complex Subunit 160%
see_also📖KAT2A (Lysine Acetyltransferase 2A)60%
see_also📖KAT2B — Lysine Acetyltransferase 2B60%
see_also📖KAT5 — Lysine Acetyltransferase 560%
see_also📖LONP160%
see_also📖MAP1LC3A Gene60%
see_also📖MAP1LC3C Gene60%
see_also📖MAPK9 Gene60%
see_also📖MARCH7 — Membrane Associated Ring-CH Type Finger 760%
see_also📖max60%
see_also📖MCOLN1 — Mucolipin-1 (TRPML1)60%
see_also📖MELK Gene60%
see_also📖MFF Gene60%
see_also📖MS4A6A Gene60%
see_also📖NDUFV2 Gene60%
see_also📖NLRC4 Gene60%
see_also📖NOD2 Gene60%
see_also📖npc160%
see_also📖NR1D1 — Nuclear Receptor Subfamily 1 Group D Member 1 (REV-E60%
see_also📖NSF Gene60%
see_also📖PAH Gene60%
see_also📖PANK2 — Pantothenate Kinase 260%
see_also📖PDPK1 Gene60%
see_also📖pex1460%
see_also📖pik3cb60%
see_also📖PLIN1 — Perilipin 160%
see_also📖pnpla660%
see_also📖polg60%
see_also📖PPP1CB Gene60%
see_also📖PPP3CB Gene60%
see_also📖PSMB960%
see_also📖BBC3 — BCL2 Binding Component 3 (PUMA)60%
see_also📖RAB11A — Ras-Related Protein Rab-11A60%
see_also📖RAB2A Gene60%
see_also📖RAB39B Gene60%
see_also📖RAB7 Gene60%
see_also📖RAB9A60%
see_also📖RALB Gene - RAS-Related Protein Ral-B60%
see_also📖ripk260%
see_also📖RPS6 Gene60%
see_also📖RUBCN Gene60%
see_also📖S100A8 - S100 Calcium Binding Protein A860%
see_also📖SERPINA3 Gene — Alpha-1 Antichymotrypsin in Neurodegeneratio60%
see_also📖SHANK3 - SH3 and Multiple Ankyrin Repeat Domains 360%
see_also📖SIGMAR1 Gene60%
see_also📖SMN1 - Survival Motor Neuron 160%
see_also📖SMPD1 Gene - Acid Sphingomyelinase60%
see_also📖SPG20 Gene60%
see_also📖STIP1 Gene60%
see_also📖STUB1 — CHIP60%
see_also📖SYNJ1 — Synaptojanin 160%
see_also📖TAAR1 — Trace Amine-Associated Receptor 160%
see_also📖TCF4 Gene60%
see_also📖TFRC60%
see_also📖TIA1 - TIA1 Cytotoxic Granule Associated RNA Binding Protein60%
see_also📖TNFRSF1A Gene60%
see_also📖TRAIL Gene (TNFSF10)60%
see_also📖TPP1 Gene - Tripeptidyl Peptidase 160%
see_also📖TRAF2 Gene60%
see_also📖tufm60%
see_also📖UBE2D160%
see_also📖ULK2 Gene60%
see_also📖VAMP7 Gene60%
see_also📖VPS13D Gene60%
see_also📖WDFY3 Gene60%
see_also📖WDR41 Gene60%
see_also📖WDR45 - WD Repeat Domain 4560%
see_also📖XPC — Xeroderma Pigmentosum Complementation Group C60%
see_also📖YY1 — Yin Yang 160%
see_also📖AXIN2 Protein60%
see_also📖CASP4 Protein60%
see_also📖ITPR1 Gene60%
see_also📖MAX Protein (MAX)60%
see_also📖PAH Protein60%
see_also📖RAB7 Protein60%
see_also📖STUB1/CHIP Protein60%
see_also📖SYNJ1 Protein60%
see_also📖Update TDP-43 protein page with comprehensive content60%
see_also📖TIA1 Protein60%
see_also📖proteins-tia1-protein60%
see_also📖VPS13D Protein60%
see_also📖proteins-vps13d-protein60%
see_also📖Mitch A. Max60%
see_also📖IL16 Gene60%
see_also📖Neurodegeneration60%
see_also📖GSK-3β60%
see_also📖ATG2A60%
see_also📖socs160%
see_also📖TXNRD1 — Thioredoxin Reductase 160%
see_also📖WIPI4 Gene60%
see_also📖ABCG1 Gene60%
see_also📖ADORA2A Gene60%
see_also📖DYSF — Dysferlin60%
see_also📖GNAL — Gαolf Subunit60%
see_also📖IGF2BP160%
see_also📖SLC7A1 Gene60%
see_also📖SMCR8 Gene60%
see_also📖TOLLIP — Toll-Interacting Protein60%
see_also📖trim260%
see_also📖Hepsin Protein60%
see_also📖IRE1/ERN1 (Inositol-Requiring Enzyme 1)60%
see_also📖BAX Gene60%
see_also📖BECN1 Gene60%
see_also📖BMAL1 (ARNTL) Gene60%
see_also📖BNIP3 Gene60%
see_also📖ERCC2 Gene - Excision Repair Cross-Complementation Group 260%
see_also📖GALC Gene60%
see_also📖RNF5 — RING Finger Protein 560%
see_also📖TMEM175 Gene60%
see_also📖TMEM175 Lysosomal Modulation Therapy60%
see_also📖Synaptogenesis in Neurodegeneration60%
see_also📖TMEM175 Protein60%
see_also📖TMEM175 Protein60%
see_also📖BCL2L1 Gene60%
see_also📖BDNF Gene60%
see_also📖c1q60%
see_also📖ST6GALNAC5 Gene60%
see_also📖St6galnac5 (ST6 N-acetylneuraminic acid alpha-2,6-sialyltran60%
see_also📖Clusterin (ApoJ) - AD Biomarker60%
see_also📖Vimentin - Biomarker60%
see_also📖Hippocampus60%
see_also📖ALDH1A3 — Aldehyde Dehydrogenase 1 Family Member A360%
see_also📖AMPD2 — Adenosine Monophosphate Deaminase 260%
see_also📖ATF2 — Activating Transcription Factor 260%
see_also📖atg10160%
see_also📖BRG1 Gene60%
see_also📖CELF2 Gene60%
see_also📖CFLAR60%
see_also📖CLCN7 Gene60%
see_also📖CLU Gene - Clusterin60%
see_also📖CXCR4 Gene60%
see_also📖EIF4G1 Gene60%
see_also📖gnptg60%
see_also📖HNRNPK Gene60%
see_also📖IL12B Gene - Interleukin 12 Beta60%
see_also📖MAP1LC3B2 Gene60%
see_also📖MOG Gene60%
see_also📖PER3 Gene60%
see_also📖PRKCB — Protein Kinase C Beta60%
see_also📖S100A9 - S100 Calcium Binding Protein A960%
see_also📖STAT6 — Signal Transducer and Activator of Transcription 660%
see_also📖WDR81 — WD Repeat Domain 8160%
see_also📖Clusterin Protein60%
see_also📖Clusterin (CLU / Apolipoprotein J)60%
see_also📖cxcr460%
see_also📖EIF4G1 Protein60%
see_also📖Vimentin Protein60%
see_also📖ctsl60%
see_also📖ddx5860%
see_also📖ESRRA (Estrogen-Related Receptor Alpha) Gene60%
see_also📖PLK2 Gene60%
see_also📖RPL2660%
see_also📖RPN1 Gene60%
see_also📖SPG11 Gene - Spastic Paraplegia 1160%
see_also📖SPG15 Gene - Spastic Paraplegia 1560%
see_also📖SPG11 Cytoskeletal Protein60%
see_also📖acc-chronic-pain60%
see_also📖PP2A (Redirect)60%
see_also📖Traumatic Brain Injury and Alzheimer's Disease Relation60%
see_also📖ADRB2 Gene60%
see_also📖ARRB1 — Arrestin Beta 160%
see_also📖BAG260%
see_also📖BMPR1A — Bone Morphogenetic Protein Receptor Type 1A60%
see_also📖CAMKK2 Gene60%
see_also📖CBLN1 Gene60%
see_also📖CDK6 Gene60%
see_also📖cdkn2a60%
see_also📖ctss60%
see_also📖CYCS60%
see_also📖DLK — Dual Leucine Zipper Kinase60%
see_also📖DMT1 Gene60%
see_also📖EEF2K — Eukaryotic Elongation Factor 2 Kinase60%
see_also📖EIF2AK2 — Eukaryotic Translation Initiation Factor 2 Alpha K60%
see_also📖FGFR2 — Fibroblast Growth Factor Receptor 260%
see_also📖FKBP1A60%
see_also📖GLUD1 - Glutamate Dehydrogenase 160%
see_also📖grid160%
see_also📖HDAC1 Gene60%
see_also📖HSF1 Gene - Heat Shock Factor 160%
see_also📖HSPB1 — Heat Shock Protein Family B Member 160%
see_also📖IGF2BP260%
see_also📖JAG1 — Jagged 160%
see_also📖KIF5A Gene60%
see_also📖NFATc1 — Nuclear Factor of Activated T Cells 160%
see_also📖NOTCH2NLC Gene60%
see_also📖PP2A (PPP2R1A)60%
see_also📖PPT1 Gene - Palmitoyl-Protein Thioesterase 160%
see_also📖PRKCD — Protein Kinase C Delta60%
see_also📖PRKCQ60%
see_also📖PRMT560%
see_also📖RAB27A Gene60%
see_also📖RHEB Gene60%
see_also📖RICTOR Gene60%
see_also📖RNF13 — Ring Finger Protein 1360%
see_also📖SIRT2 Gene60%
see_also📖SRSF160%
see_also📖steap360%
see_also📖UCP2 — Uncoupling Protein 260%
see_also📖UGCG Gene60%
see_also📖USP14 Gene60%
see_also📖VPS4A — Vacuolar Protein Sorting 4 Homolog A60%
see_also📖Oxidative Stress in Corticobasal Syndrome60%
see_also📖Oxidative Stress in Neurodegeneration60%
see_also📖Oxidative Stress in Neurodegeneration60%
see_also📖Oxidative Stress Pathway60%
see_also📖BAG2 Protein60%
see_also📖DMT1 (Divalent Metal Transporter 1)60%
see_also📖PP2A Protein60%
see_also📖RICTOR Protein60%
see_also📖Uncoupling Protein 2 (UCP2)60%
see_also📖ABCD3 Gene60%
see_also📖ADNP Gene60%
see_also📖APE1 — AP Endonuclease 160%
see_also📖ARHGEF7 Gene60%
see_also📖CDK2 Gene60%
see_also📖DEPTOR60%
see_also📖gnai1 Gene60%
see_also📖GNAI2 Gene60%
see_also📖gnas Gene60%
see_also📖GNB1 Gene - G Protein Subunit Beta 160%
see_also📖GNG2 Gene60%
see_also📖GRB2 — Growth Factor Receptor Bound Protein 260%
see_also📖GRK2 — G Protein-Coupled Receptor Kinase 260%
see_also📖IFIH1 Gene (MDA5)60%
see_also📖L1CAM (L1 Cell Adhesion Molecule)60%
see_also📖MAP3K5 — Mitogen-Activated Protein Kinase Kinase Kinase 560%
see_also📖MLST8 Gene60%
see_also📖NOS3 — Nitric Oxide Synthase 360%
see_also📖plin360%
see_also📖PTK2 Gene - Focal Adhesion Kinase60%
see_also📖RAB1A — Ras-Related Protein Rab-1A60%
see_also📖RAB7L1 (RAB7 Like 1)60%
see_also📖retreg360%
see_also📖RGS2 Gene - Regulator of G Protein Signaling 260%
see_also📖RPTOR — Regulatory Associated Protein of MTOR Complex 160%
see_also📖RRAGA — Ras-Related GTP Binding A60%
see_also📖rragb60%
see_also📖SYNPO2 — Synaptopodin 260%
see_also📖Endothelial Nitric Oxide Synthase (NOS3)60%
see_also📖DNAJC16 Gene60%
see_also📖NHLRC2 Gene60%
see_also📖DNAJC16 Protein60%
see_also📖Cochlear Hair Cells in Aging60%
see_also📖Cochlear Hair Cells in Age-Related Hearing Loss60%
see_also📖Cochlear Hair Cells in Auditory Neuropathy Spectrum Disorder60%
see_also📖NeuRon Therapeutics60%
see_also📖NLRP1 Gene60%
see_also📖Alzheimer Indonesia60%
see_also📖Protein Aggregation in Neurodegenerative Disease Comparison60%
see_also📖Mitochondria60%
see_also📖p62/SQSTM1 (Sequestosome-1)60%
see_also📖Reactive Oxygen Species (ROS)60%
see_also📖ABI3 Gene60%
see_also📖ABIN1 (TNIP1) Gene60%
see_also📖ADCY9 Gene60%
see_also📖ADRA1D Gene60%
see_also📖ar60%
see_also📖ATP2A2 Gene60%
see_also📖ATXN3 — Ataxin-360%
see_also📖CALM2 Gene60%
see_also📖cct260%
see_also📖Class II Major Histocompatibility Complex Transactivator60%
see_also📖CYLD Gene60%
see_also📖DDX20 Gene (DEAD-Box Helicase 20 / Gemin3)60%
see_also📖DUSP1 Gene60%
see_also📖E2F1 Gene60%
see_also📖eno160%
see_also📖EZH2 — Enhancer of Zeste Homolog 260%
see_also📖FGF18 Gene60%
see_also📖FOXG1 — Forkhead Box G160%
see_also📖fxn60%
see_also📖idh3a60%
see_also📖igf2bp360%
see_also📖IL4 Gene60%
see_also📖il6r60%
see_also📖LITAF — Lipopolysaccharide-Induced Tumor Necrosis Factor Fac60%
see_also📖LRP2 — Low Density Lipoprotein Receptor-Related Protein 2 (M60%
see_also📖lyst60%
see_also📖MAPK10 Gene60%
see_also📖MIEF2 — Mitochondrial Elongation Factor 2 (MiD50)60%
see_also📖MYH2 Gene60%
see_also📖ndrg260%
see_also📖nfkbia60%
see_also📖NLRC5 — NLR Family CARD Domain Containing 560%
see_also📖NPY1R Gene60%
see_also📖OTULIN — OTU Deubiquitinase with Linear Linkage Specificity60%
see_also📖PDIA3 - Protein Disulfide Isomerase Family A Member 360%
see_also📖pdk460%
see_also📖PIEZO2 — Piezo Type Mechanosensitive Ion Channel Component 260%
see_also📖PIK3R1 Gene60%
see_also📖plekhg560%
see_also📖PPP2R2B Gene60%
see_also📖PPP5C — Protein Phosphatase 5 Catalytic Subunit60%
see_also📖PRKDC — DNA-Dependent Protein Kinase Catalytic Subunit60%
see_also📖PSMC1 (Proteasome 26S Subunit ATPase 1)60%
see_also📖rab5c60%
see_also📖REST Gene60%
see_also📖RTN4 Gene60%
see_also📖SCD1 Gene60%
see_also📖SEC22B Gene60%
see_also📖SESN1 Gene60%
see_also📖SHARPIN — SHANK Associated RH Domain Interactor60%
see_also📖SNAP23 Gene60%
see_also📖STX3 Gene60%
see_also📖STX4 — Syntaxin-460%
see_also📖TIGAR - TP53-Induced Glycolysis and Apoptosis Regulator60%
see_also📖TPM1 — Tropomyosin 160%
see_also📖TPPP Gene60%
see_also📖TRIM16 — Tripartite Motif-Containing Protein 1660%
see_also📖TWNK Gene60%
see_also📖UBE2K Gene60%
see_also📖VPS16 Gene60%
see_also📖vps2660%
see_also📖VPS37B Gene60%
see_also📖WIPI3 Gene60%
see_also📖XIAP60%
see_also📖XPA Gene60%
see_also📖m6A RNA Methylation Modulation Therapy for Neurodegeneration60%
see_also📖Age-Sensitive Cortical Vulnerability in Parkinson's Dis60%
see_also📖Lysosome Dysfunction in Neurodegeneration60%
see_also📖m6A RNA Methylation (Epitranscriptomics) in Neurodegeneratio60%
see_also📖Microglial Phagocytosis in Neurodegeneration60%
see_also📖Protein Homeostasis in Neurodegeneration60%
see_also📖Protein Quality Control in Neurodegeneration60%
see_also📖Ataxin-3 (ATXN3)60%
see_also📖Calmodulin 2 (CALM2)60%
see_also📖LRP2 Protein (Megalin)60%
see_also📖PLEKHG5 Protein60%
see_also📖PPP5C Protein60%
see_also📖VPS16 Protein60%
see_also📖Acupuncture Therapy for Parkinson's Disease60%
see_also📖Acupuncture Therapy for Neurodegeneration60%
see_also📖Acupuncture Therapy for Parkinson's Disease60%
see_also📖Acupuncture and TCM for Atypical Parkinsonism60%
see_also📖USP7 Gene60%
see_also📖DTI White Matter Changes in CBS/PSP60%
see_also📖Sleep Biomarkers for CBS and PSP60%
see_also📖Locus Coeruleus Noradrenergic in Progressive Supranuclear Pa60%
see_also📖Nigral Microglia in Progressive Supranuclear Palsy60%
see_also📖Pedunculopontine Nucleus Cholinergic in Progressive Supranuc60%
see_also📖Red Nucleus Psp60%
see_also📖Subthalamic Nucleus Neurons in Progressive Supranuclear Pals60%
see_also📖AMX0035 for Progressive Supranuclear Palsy60%
see_also📖BIIB080 (MAPTRx) ASO Therapy for PSP60%
see_also📖Davunetide (AL-108) PSP Trial60%
see_also📖First-in-Human 4R Tau Ligand Study in PSP60%
see_also📖FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear 60%
see_also📖Gosuranemab (BIIB092) PSP Trial60%
see_also📖gv1001-psp60%
see_also📖Lithium Carbonate PSP Trial60%
see_also📖LY-3372689 LOTUS Trial - Phase 2 in Progressive Supranuclear60%
see_also📖NADAPT Study: NAD Replenishment Therapy for Atypical Parkins60%
see_also📖nct02605785-tau-pet-psp60%
see_also📖neflamapimod-psp60%
see_also📖NIO752 Tau ASO PSP Trial60%
see_also📖Syde® Digital Endpoints for PSP (NCT07389018)60%
see_also📖tetrabenazine-psp60%
see_also📖Tilavonemab PSP Trial Failure Analysis60%
see_also📖TPN-101 for Progressive Supranuclear Palsy60%
see_also📖Typhaneoside for Progressive Supranuclear Palsy60%
see_also📖UCB0107 for Progressive Supranuclear Palsy60%
see_also📖Eye Tracking and Saccade Testing in Progressive Supranuclear60%
see_also📖Metabolic Imaging and PET Tracers in CBS/PSP60%
see_also📖Neuropsychological Testing in CBS and PSP60%
see_also📖Polysomnography and Sleep Study Testing for Atypical Parkins60%
see_also📖Salivary Biomarkers in Corticobasal Syndrome60%
see_also📖transcranial-sonography-cbs-psp60%
see_also📖Whole Genome Sequencing for CBS/PSP60%
see_also📖Progressive Supranuclear Palsy (PSP)60%
see_also📖PSP Rating Scale (PSPRS)60%
see_also📖Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
see_also📖Brainstem Circuit Modulation for PSP60%
see_also📖CRISPR Gene Correction Approaches for CBS/PSP60%
see_also📖N-of-1 Clinical Trial Design for CBS/PSP60%
see_also📖AURKA Gene60%
see_also📖BIRC5 (Survivin)60%
see_also📖casp860%
see_also📖CDKN1B — Cyclin-Dependent Kinase Inhibitor 1B60%
see_also📖CNBP — Cellular Nucleic Acid Binding Protein60%
see_also📖KIF20A — Kinesin Family Member 20A60%
see_also📖ppard60%
see_also📖PSP Gene - Persephin60%
see_also📖SPP1 Gene60%
see_also📖txnip60%
see_also📖Personalized Antisense Oligonucleotide (ASO) Therapy60%
see_also📖Axonal Transport Dysfunction in Progressive Supranuclear Pal60%
see_also📖Computational Models of Tau Propagation in Progressive Supra60%
see_also📖Computational Tau Spreading Models in Progressive Supranucle60%
see_also📖Exosome-Mediated Tau Propagation in Progressive Supranuclear60%
see_also📖Heat Shock Protein Dysfunction in Progressive Supranuclear P60%
see_also📖integrin-ecm-signaling-cbs-psp60%
see_also📖lipid-metabolism-psp60%
see_also📖Metabolomic Alterations in Progressive Supranuclear Palsy60%
see_also📖Neurotransmitter Dysfunction in Progressive Supranuclear Pal60%
see_also📖Oligodendroglial Involvement in Progressive Supranuclear Pal60%
see_also📖Ribosomal and Translation Dysfunction in Progressive Supranu60%
see_also📖Selective Neuronal Vulnerability in Progressive Supranuclear60%
see_also📖Vascular and Endothelial Dysfunction in Progressive Supranuc60%
see_also📖PSP Australia60%
see_also📖PSP Canada60%
see_also📖PSP France60%
see_also📖PSP Germany60%
see_also📖PSP Italy — Associazione Italiana PSP60%
see_also📖PSP Japan — 日本PSP協会60%
see_also📖PSP Netherlands — PSP Vereniging Nederland60%
see_also📖PSP Scandinavia60%
see_also📖PSP Spain — Asociación Española de PSP60%
see_also📖PSP Association UK60%
see_also📖cognitive-reserve-cbs-psp60%
see_also📖combination-therapy-cbs-psp60%
see_also📖Hormone Neuroprotection in CBS/PSP60%
see_also📖pharmacogenomics-cbs-psp60%
see_also📖protective-strategies-cbs-psp60%
see_also📖section-155-art-therapy-creative-arts-therapies-cbs-psp60%
see_also📖section-181-advanced-music-rhythm-therapy-cbs-psp60%
see_also📖section-186-crispr-base-editing-therapeutics-cbs-psp60%
see_also📖section-197-advanced-clinical-trial-design-cbs-psp60%
see_also📖section-198-advanced-precision-medicine-implementation-cbs-p60%
see_also📖section-209-glp-1-receptor-agonists-cbs-psp60%
see_also📖section-228-advanced-dance-movement-therapy-cbs-psp60%
see_also📖section-239-advanced-light-therapy-photobiomodulation-cbs-ps60%
see_also📖section-242-advanced-stem-cell-therapy-neuronal-replacement-60%
see_also📖Tirzepatide and Dual GIP/GLP-1 Agonists for Neurodegeneratio60%
mentions🧪Cryptic Exon Silencing Restoration55%
mentions🧪Glycine-Rich Domain Competitive Inhibition55%
mentions🧪Cross-Seeding Prevention Strategy55%
see_also📖Long-term Effects of Hearing Intervention on Brain Health in55%
see_also📖Multimodal Diagnostic Algorithm for CBS and PSP55%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration54%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur54%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi54%
related🧫Proposed experiment from debate on Epigenetic clocks and bio54%
related🧫Proposed experiment from debate on Microglia activate astroc54%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur54%
related🧫Proposed experiment from debate on Epigenetic clocks and bio54%
related🧫s:** - Temporal analysis showing mitochondrial defects prece54%
related🧫s:** - Test MCU overexpression specifically in layer II neur54%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l54%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l54%
related🧫s:** - Compare uptake with/without magnetic particles using 54%
related🧫Proposed experiment from debate on Perivascular spaces and g54%
related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice54%
related🧫Proposed experiment from debate on Mitochondrial transfer be54%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional54%
related🧫Proposed experiment from debate on Perivascular spaces and g54%
related🧫Proposed experiment from debate on Mitochondrial transfer be54%
related🧫s:** - Dose-response studies showing therapeutic window with54%
related🧫Proposed experiment from debate on Senolytics targeting p16/54%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy54%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka54%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi54%
related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr54%
related🧫DLB Cognitive Fluctuation Mechanism Experiment54%
related🧫Genetic Risk Modifiers in DLB Phenotype54%
related🧫Tau Co-Pathology in DLB Clinical Heterogeneity54%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras54%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 54%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P54%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther54%
related🧫Experiment Index54%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M54%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin54%
related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment54%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design54%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre54%
related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 54%
related🧫NPH Glymphatic System Interaction Experiment54%
related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G54%
related🧫Prion Strain Diversity and Selective Vulnerability in CJD54%
related🧫Protein Aggregation Kinetic Validation Results54%
related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel54%
related🧫Experiment Scoring Methodology54%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec54%
related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati54%
related🧫Tau Pathology Initiation Zone Identification54%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo54%
related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro54%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in54%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an54%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 54%
mentions🧪Temporal Decoupling via Circadian Clock Reset50%
mentions🧪Netrin-1 Gradient Restoration50%
mentions🧪Smartphone-Detected Motor Variability Correction50%
mentions🧪Purinergic Signaling Polarization Control50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪Ganglioside Rebalancing Therapy50%
mentions🧪Mitochondrial RNA Granule Rescue Pathway50%
mentions🧪Complement C1q Mimetic Decoy Therapy50%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
mentions🧪Retinal Vascular Microcirculation Rescue50%
mentions🧪Noradrenergic-Tau Propagation Blockade50%
mentions🧪Adenosine-Astrocyte Metabolic Reset50%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪SASP-Mediated Complement Cascade Amplification50%
mentions🧪Complement C1q Subtype Switching50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪Ocular Immune Privilege Extension50%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%
mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation50%
mentions🧪Extracellular Matrix Stiffness Modulation50%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%
mentions🧪Axonal RNA Transport Reconstitution50%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%
mentions🧪Digital Twin-Guided Metabolic Reprogramming50%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
mentions🧪Aquaporin-4 Polarization Rescue50%
mentions🧪Senescence-Activated NAD+ Depletion Rescue50%
mentions🧪Epigenetic Memory Erasure via TET2 Activation50%
mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪Mechanosensitive Ion Channel Reprogramming50%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%
mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%
mentions🔬Extracellular vesicle biomarkers for early AD detection50%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
mentions🔬Senescent cell clearance as neurodegeneration therapy50%
mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr50%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model50%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen50%
mentions🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 50%
mentions🧫Macroautophagy Dysfunction in PD - Experiment Design50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪Mitochondrial SPM Synthesis Platform Engineering50%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%
mentions🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%
mentions🧪Multi-Modal Stress Response Harmonization50%
mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%
mentions🧪CYP46A1 Overexpression Gene Therapy50%
mentions🧪Liquid-Liquid Phase Separation Modifier Therapy50%
mentions🧪PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor50%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
mentions🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar50%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%
mentions🧪Targeted Butyrate Supplementation for Microglial Phenotype M50%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%
mentions🧪Quantum Coherence Disruption in Cellular Communication50%
mentions🧪The Glial Ketone Metabolic Shunt Hypothesis50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%
mentions🧪APOE-Dependent Autophagy Restoration50%
mentions🧪Extracellular Vesicle Biogenesis Modulation50%
mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting50%
mentions🧪Microglial Purinergic Reprogramming50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪Autophagosome Maturation Checkpoint Control50%
mentions🧪Sphingolipid Metabolism Reprogramming50%
mentions🧪PARP1 Inhibition Therapy50%
mentions🧪Low Complexity Domain Cross-Linking Inhibition50%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading50%
mentions🧪Piezoelectric Nanochannel BBB Disruption50%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis50%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches50%
mentions🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci50%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪Orexin-Microglia Modulation Therapy50%
mentions🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption50%
mentions🧪Lysosomal Calcium Channel Modulation Therapy50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
mentions🧪Membrane Cholesterol Gradient Modulators50%
mentions🧪Flotillin-1 Stabilization Compounds50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧪HDAC3-Selective Inhibition for Clock Reset50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪Lysosomal Positioning Dynamics Modulation50%
mentions🧪Lysosomal Enzyme Trafficking Correction50%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%
mentions🧪Senescence-Associated Myelin Lipid Remodeling50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%
mentions🧪Transglutaminase-2 Cross-Linking Inhibition Strategy50%
mentions🧪Microglia-Derived Extracellular Vesicle Engineering for Targ50%
mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%
mentions🧪Vocal Cord Neuroplasticity Stimulation50%
mentions🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction50%
mentions🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling50%
mentions🧪Ephrin-B2/EphB4 Axis Manipulation50%
mentions🧪Microbial Inflammasome Priming Prevention50%
mentions🧪Phase-Separated Organelle Targeting50%
mentions🧪Nucleolar Stress Response Normalization50%
mentions🧪Vagal Afferent Microbial Signal Modulation50%
mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%
mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
mentions🧪Sphingomyelin Synthase Activators for Raft Remodeling50%
mentions🧪RNA Granule Nucleation Site Modulation50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro50%
mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro50%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%
mentions🧪APOE-TREM2 Interaction Modulation50%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪VCP-Mediated Autophagy Enhancement50%
mentions🧪Transcriptional Autophagy-Lysosome Coupling50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%
mentions🧪Circadian-Synchronized Proteostasis Enhancement50%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement50%
mentions🧪Lysosomal Membrane Repair Enhancement50%
mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement50%
mentions🧪Mitochondrial Transfer Pathway Enhancement50%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation50%
mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%
mentions🧪R-Loop Resolution Enhancement Therapy50%
mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme50%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬Does TFEB dysfunction cause neurodegeneration or represent a50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Extracellular vesicle biomarkers for early AD detection50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Senescent cell clearance as neurodegeneration therapy50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar50%
see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre50%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh50%
see_also📖al002-trem2-agonist-alzheimers50%
see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro50%
see_also📖Utilisation of Health Services and Quality of Life in Atypic50%
see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini50%
see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month50%
see_also📖A Multicenter, Phase III, Randomized, Double Blind, Placebo-50%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 50%
see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co50%
see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr50%
see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi50%
see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc50%
see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)50%
see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid50%
see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd50%
see_also📖Physical and Occupational Therapy in Corticobasal Syndrome50%
see_also📖Healthcare Economics and Cost of Illness in Progressive Supr50%
see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O50%
see_also📖Rigidity in Corticobasal Syndrome50%
see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro50%
see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease50%
see_also📖APOE4 and Alzheimer's Disease Risk50%
see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP50%
see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for50%
see_also📖Braak Staging and Tau Propagation Pathway50%
see_also📖CBS/PSP Panxoneopathy and Membrane Biology50%
see_also📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise50%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t50%
see_also📖Glial Tau Pathology in PSP and CBD50%
see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova50%
see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath50%
see_also📖Neuroinflammation in Parkinson's Disease Dementia and D50%
see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031050%
see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 50%
see_also📖Synaptic Loss and Dysfunction Pathway50%
see_also📖Systemic Infection and Tau Pathology Acceleration50%
see_also📖Tau Seeding and Propagation Pathway50%
see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality50%
see_also📖AAIC 2026: Tau-PET Imaging and Fluid Biomarker Integration45%
see_also📖Alpha-Synuclein PET Imaging and Biomarker Advances45%
see_also📖Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)45%
see_also📖Aquaporin-4 (AQP4) - Glymphatic System Biomarker45%
see_also📖Imaging Biomarkers for Corticobasal Syndrome and Progressive45%
see_also📖Multi-Analyte Biomarker Panel for Parkinson's Disease D45%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%
see_also📖Polygenic Risk Score Integration Panel for Alzheimer's 45%
see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy45%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%
see_also📖BLAAC PD - Black and African Americans Connections to PD (NC45%
see_also📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa45%
see_also📖CNversyt and Megan Rodden ALS Trials45%
see_also📖Cognitive and Speech Rehabilitation in CBS (NCT05823421)45%
see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat45%
see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial45%
see_also📖First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)45%
see_also📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo45%
see_also📖Gait and Upper Limb Evaluation in PSP (NCT07136844)45%
see_also📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi45%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime45%
see_also📖Safety and Clinical Outcomes Study: Amniotic and Umbilical C45%
see_also📖A Phase III, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-C45%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di45%
see_also📖A Phase 3, Randomized, Double-blind, Placebo-controlled, Par45%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%
see_also📖Whole-Body Photobiomodulation for Motor and Cognitive Change45%
see_also📖Quality of Life and Caregiver Burden in PSP (NCT03638505)45%
see_also📖Silymarin for Neuroprotection and Symptom Management in Park45%
see_also📖Social Behaviors and Quality of Life in Parkinson's Dis45%
see_also📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par45%
see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717045%
see_also📖UB-311 Alzheimer's Vaccination Trial45%
see_also📖alexander-disease45%
see_also📖Alexander Disease Genetic Variants45%
see_also📖ATP13A9 and Parkinson's Disease45%
see_also📖Callosal Disconnection and Interhemispheric Dysfunction in C45%
see_also📖Caregiver Burden and Support in Corticobasal Syndrome45%
see_also📖Caregiver Support and Palliative Care in Atypical [Parkinson45%
see_also📖Clinical Phenotypes and Subtypes of Corticobasal Syndrome45%
see_also📖Natural History and Prognosis of Corticobasal Syndrome45%
see_also📖Dysphagia and Nutritional Management in Corticobasal Syndrom45%
see_also📖Environmental Toxins and Parkinson's Risk45%
see_also📖HIV-Associated Neurocognitive Disorders (HAND)45%
see_also📖Hemiballismus and Hemichorea in Corticobasal Syndrome45%
see_also📖Investment Landscape: ALS45%
see_also📖Investment Landscape: Frontotemporal Dementia45%
see_also📖Investment Landscape: Huntington's Disease45%
see_also📖Investment Landscape: Parkinson's Disease45%
see_also📖Japanese and German Case Series in Corticobasal Degeneration45%
see_also📖Jervell and Lange-Nielsen Syndrome45%
see_also📖LRRK2 Gene Variants and Mutations45%
see_also📖Nutritional Support and Dietary Interventions in Corticobasa45%
see_also📖Postural Dysfunction and Abnormalities in Corticobasal Syndr45%
see_also📖Pseudobulbar Affect and Emotional Lability in Corticobasal S45%
see_also📖Quality of Life and Caregiver Burden in Progressive Supranuc45%
see_also📖Speech and Voice Disorders in PSP45%
see_also📖Sandhoff Disease45%
see_also📖Sialorrhea and Drooling in Corticobasal Syndrome45%
see_also📖Simultanagnosia and Balint's Syndrome in Corticobasal S45%
see_also📖SNCA A53T45%
see_also📖TARDBP Mutations in Amyotrophic Lateral Sclerosis45%
see_also📖Vocational Rehabilitation and Driving in Corticobasal Syndro45%
see_also📖Voice and Speech in Corticobasal Syndrome45%
see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 45%
see_also📖ALS Biomarkers and Disease Monitoring45%
see_also📖C9orf72 Repeat Expansions in CBS and PSP45%
see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn45%
see_also📖VEGF and Angiogenesis Dysregulation in CBS/PSP45%
see_also📖Pupillometry and Chromatic Pupillometry in Corticobasal Synd45%
see_also📖FTDP-17 Clinical Phenotypes and Disease Progression45%
see_also📖FTLD-TDP Subtypes and Mechanisms45%
see_also📖Iron and Neuromelanin Accumulation in PSP45%
see_also📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par45%
see_also📖MSA Clinical Features and Diagnosis45%
see_also📖mTOR Signaling in Autophagy and Lysosomal Function45%
see_also📖Neuroresilience Mechanisms and Evidence45%
see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%
see_also📖NLRP3 Inhibitors in Parkinson's Disease: Research and C45%
see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P45%
see_also📖Gait and Balance Disorders in Progressive Supranuclear Palsy45%
see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP45%
see_also📖PSP Lysosomal Dysfunction and Autophagy Impairment45%
see_also📖Pupillary and Visual Dysfunction in Progressive Supranuclear45%
see_also📖PSP Tau Propagation and Spreading Mechanisms45%
see_also📖PSP Weight Loss and Cachexia45%
see_also📖Sleep Architecture Changes in CBS and PSP45%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%
see_also📖Somatic Mutations and Brain Mosaicism45%
see_also📖Speech and Language Deficits in Corticobasal Syndrome45%
see_also📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain45%
mentions🧫Functional validation of trehalose effects on misfolded prot44%
mentions🧫Trehalose-induced lysosomal changes and TFEB activation44%
mentions🧫Trehalose-induced lysosomal membrane permeabilization and TF44%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar40%
related🧪Temporal Decoupling via Circadian Clock Reset40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%
related🧪Netrin-1 Gradient Restoration40%
related🧪Smartphone-Detected Motor Variability Correction40%
related🧪Purinergic Signaling Polarization Control40%
related🧪Mitochondrial-Lysosomal Contact Site Engineering40%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 40%
related🧪Circadian-Synchronized Proteostasis Enhancement40%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪HSP90-Tau Disaggregation Complex Enhancement40%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%
related🧪Ganglioside Rebalancing Therapy40%
related🧪Mitochondrial SPM Synthesis Platform Engineering40%
related🧪CX43 hemichannel engineering enables size-selective mitochon40%
related🧪VCP-Mediated Autophagy Enhancement40%
related🧪Arginine Methylation Enhancement Therapy40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪SASP-Mediated Cholinergic Synapse Disruption40%
related🧪Mitochondrial RNA Granule Rescue Pathway40%
related🧪Multi-Modal Stress Response Harmonization40%
related🧪Complement C1q Mimetic Decoy Therapy40%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc40%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪Enteric Nervous System Prion-Like Propagation Blockade40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪Retinal Vascular Microcirculation Rescue40%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition40%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho40%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪Noradrenergic-Tau Propagation Blockade40%
related🧪Adenosine-Astrocyte Metabolic Reset40%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones40%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists40%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%
related🧪Quantum Coherence Disruption in Cellular Communication40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪Cryptic Exon Silencing Restoration40%
related🧪SIRT6-NAD+ Axis Enhancement Therapy40%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics40%
related🧪Extracellular Vesicle Biogenesis Modulation40%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
related🧪SASP-Mediated Complement Cascade Amplification40%
related🧪Complement C1q Subtype Switching40%
related🧪Microglial Purinergic Reprogramming40%
related🧪Heat Shock Protein 70 Disaggregase Amplification40%
related🧪Autophagosome Maturation Checkpoint Control40%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%
related🧪Prefrontal sensory gating circuit restoration via PV interne40%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement40%
related🧪Sphingolipid Metabolism Reprogramming40%
related🧪PARP1 Inhibition Therapy40%
related🧪Low Complexity Domain Cross-Linking Inhibition40%
related🧪Ocular Immune Privilege Extension40%
related🧪Hypocretin-Neurogenesis Coupling Therapy40%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation40%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu40%
related🧪Extracellular Matrix Stiffness Modulation40%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism40%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation40%
related🧪Perforant Path Presynaptic Terminal Protection Strategy40%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor40%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%
related🧪Senescence-Induced Lipid Peroxidation Spreading40%
related🧪Piezoelectric Nanochannel BBB Disruption40%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis40%
related🧪Lipid Droplet Dynamics as Phenotype Switches40%
related🧪Circadian-Synchronized LRP1 Pathway Activation40%
related🧪Glycine-Rich Domain Competitive Inhibition40%
related🧪SASP-Driven Aquaporin-4 Dysregulation40%
related🧪Axonal RNA Transport Reconstitution40%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%
related🧪Circadian-Gated Maresin Biosynthesis Amplification40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna40%
related🧪Orexin-Microglia Modulation Therapy40%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation40%
related🧪Lysosomal Membrane Repair Enhancement40%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement40%
related🧪Lysosomal Calcium Channel Modulation Therapy40%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%
related🧪Blood-Brain Barrier SPM Shuttle System40%
related🧪Mitochondrial Transfer Pathway Enhancement40%
related🧪Stress Granule Phase Separation Modulators40%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%
related🧪Pharmacological Enhancement of APOE4 Glycosylation40%
related🧪Membrane Cholesterol Gradient Modulators40%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu40%
related🧪Flotillin-1 Stabilization Compounds40%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%
related🧪HDAC3-Selective Inhibition for Clock Reset40%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪Transcriptional Autophagy-Lysosome Coupling40%
related🧪Digital Twin-Guided Metabolic Reprogramming40%
related🧪TREM2-mediated microglial tau clearance enhancement40%
related🧪Lysosomal Positioning Dynamics Modulation40%
related🧪Lysosomal Enzyme Trafficking Correction40%
related🧪Circadian Clock-Autophagy Synchronization40%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides40%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri40%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%
related🧪Senescence-Associated Myelin Lipid Remodeling40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪R-Loop Resolution Enhancement Therapy40%
related🧪Aquaporin-4 Polarization Rescue40%
related🧪Senescence-Activated NAD+ Depletion Rescue40%
related🧪Competitive APOE4 Domain Stabilization Peptides40%
related🧪Epigenetic Memory Erasure via TET2 Activation40%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%
related🧪Mechanosensitive Ion Channel Reprogramming40%
related🧪Serine/Arginine-Rich Protein Kinase Modulation40%
related🧪Selective Acid Sphingomyelinase Modulation Therapy40%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%
related🧪Vocal Cord Neuroplasticity Stimulation40%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme40%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%
related🧪Ephrin-B2/EphB4 Axis Manipulation40%
related🧪Microbial Inflammasome Priming Prevention40%
related🧪Phase-Separated Organelle Targeting40%
related🧪Nucleolar Stress Response Normalization40%
related🧪Vagal Afferent Microbial Signal Modulation40%
related🧪Cross-Seeding Prevention Strategy40%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%
related🧪Purinergic P2Y12 Inverse Agonist Therapy40%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection40%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat40%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming40%
related🧪Sphingomyelin Synthase Activators for Raft Remodeling40%
related🧪RNA Granule Nucleation Site Modulation40%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro40%
related🧪Extracellular Vesicle Biogenesis Modulation40%
related🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor40%
related🧪Liquid-Liquid Phase Separation Modifier Therapy40%
related🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective40%
related🧪HSP90-Tau Disaggregation Complex Enhancement40%
related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption40%
related🧪Prefrontal sensory gating circuit restoration via PV interne40%
related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy40%
related🧪Synaptic Vesicle Tau Capture Inhibition40%
related🧪APOE-Mediated Synaptic Lipid Raft Stabilization40%
related🧪Transglutaminase-2 Cross-Linking Inhibition Strategy40%
related🧪VCP-Mediated Autophagy Enhancement40%
related🧪Oligodendrocyte White Matter Vulnerability40%
related🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio40%
mentions🔬What are the mechanisms underlying selective vulnerability o35%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp35%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t35%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt35%
mentions🔬What are the mechanisms underlying blood-brain barrier trans35%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross35%
mentions🔬What are the mechanisms underlying apoe4 structural biology 35%
mentions🔬What are the mechanisms underlying digital biomarkers and ai35%
mentions🔬What are the mechanisms underlying senolytic therapy for age35%
mentions🔬What are the mechanisms underlying neuroinflammation resolut35%
mentions🔬What are the mechanisms underlying what are the mechanisms b35%
mentions🔬What are the mechanisms underlying what are the mechanisms b35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying protein aggregation cross35%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 35%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli35%
mentions🔬What are the mechanisms underlying sleep disruption as cause35%
mentions🔬What are the mechanisms underlying rna binding protein dysre35%
mentions🔬What are the mechanisms underlying synaptic pruning by micro35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio35%
mentions🔬What are the mechanisms underlying perivascular spaces and g35%
mentions🔬Analyze circuit-level changes in neurodegeneration using All35%
mentions🔬What gene expression changes in the aging mouse brain predic35%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di35%
mentions🔬Epigenetic reprogramming in aging neurons35%
mentions🔬Investigate prion-like spreading of tau pathology through co35%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,35%
related🔬What are the mechanisms underlying selective vulnerability o30%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub